NCT03502499

Half-normal Saline in Idiopathic Left Ventricular Outflow Tract Arrhythmias Ablation

Name: Clinical Trial NCT03502499
Creator: Texas Cardiac Arrhythmia Research Foundation
Keywords: Ventricular Arrythmia, Half-normal saline, drug, clinical trial, United States of America

Half-normal Saline vs Normal Saline for Irrigation of Open-irrigated Radiofrequency Catheters in Idiopathic Left Ventricular Outflow Tract Arrhythmias Ablation

Texas Cardiac Arrhythmia Research Foundation·ClinicalTrials.gov·drugSuspended

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Ventricular Arrythmia
Drug/Device/Intervention: Half-normal saline
Study type: Interventional
Intervention type: drug

Sponsor & location

Primary sponsor: Texas Cardiac Arrhythmia Research Foundation
Location: Aurora,Austin, United States of America

Timeline & enrollment

Phase: N/A
Start date: May 16, 2018
End date: Apr 01, 2022
Enrollment: 50 participants

Primary outcome

total radiofrequency ablation time, and total procedure time,acute success,long-term success

Summary

The study evaluates the use of half-normal saline as an irrigant for open-irrigated catheters during left ventricular outflow tract ventricular arrhythmias ablation. By increasing the efficacy of radiofrequency energy-mediated lesion formation, half-normal saline has the potential to reduce procedural times and improved acute and long-term outcomes.

ICD-10 classifications

Ventricular tachycardiaLeft ventricular failureVentricular septal defectCardiomyopathy, unspecifiedCardiac arrhythmia, unspecified

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT03502499
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT03502499 through Pure Global AI's free database. This phase not specified trial is sponsored by Texas Cardiac Arrhythmia Research Foundation and is currently Suspended. The study focuses on Ventricular Arrythmia. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.